The altered rheological properties of the blood have been shown to precede clinically detectable diabetic vasculopathy. This study seeks to investigate whether hypoglycaemic treatment would have any impact on some haemorheological markers: haematocrit (Hct), total plasma protein (TPP) and relative plasma viscosity (RPV). We studied fifty normotensive diabetic patients that were on insulin, metformin or glibenclamide treatment and 25 non-diabetic subjects matched by age, sex and body mass index (BMI). Results showed that age, BMI, haematocrit, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were similar among all groups. Fasting blood sugar (FBS) which was significantly higher (p< 0.05) in the three groups of diabetic patients when compared to that of the non-diabetic control group. The mean TPP and RPV were significantly elevated (p< 0.05 and p< 0.01 respectively) in all the diabetic groups than that observed in non-diabetic control group. In diabetic patients, FBS significantly correlated positively with RPV in either sex while weak positive correlation was found between FBS and RPV in non-diabetics. These results have shown that hyperglycaemia is associated with elevated plasma viscosity and plasma protein levels in diabetic patients. This finding suggests that treatment with insulin, metformin or glibenclamide does not impact beneficial effects on plasma rheology. In addition, the results imply that hyperglycaemia mediates hyperviscous plasma that may exert risk factor for the initiation and/or progression of diabetic vasculopathy. Hence, it may be necessary to use rheomodulators in the management of diabetes mellitus.
INTRODUCTION
Cardiovascular morbidity and mortality represent a main challenge in diabetic 1, 2 patients . Aggressive blood pressure control i n t h e m . I n t e r e s t i n t h e r o l e o f haemorheological indices in the aetiology, management, prognosis and complications of diabetes mellitus has increased. Reports in Caucasians have shown altered rheological properties of the blood of patients with 2, 4 diabetes such as increase in plasma viscosity , 2, 5 plasma protein concentrations , whole blood 2 , 4 5 , 6 viscosity and haematocrit . These alterations in haemorheological indices could explain the increase in hyperviscosity state usually associated with increased risk of cardiovascular, cerebrovascular and retinal 3, 7, 8 venous occlusion morbidity more so, that plasma viscosity and haematocrit have been 9 found to be increased in diabetic retinopathy 10 and glaucoma as well as in subjects with 11 blurred vision .
Africans are particularly prone to the 12 development of cardiovascular disease . Studies on haemorheological indices in 13 Nigerian diabetics are scarce. Memeh reported increased fibrinogen levels and blood viscosity in hypertensive diabetic Nigerians. The objective of the present study therefore is to determine alterations in some haemorheological markers after prolonged hypoglycaemic treatment in patients with diabetic mellitus. We also evaluated the relationship between fasting blood sugar and haemorheological markers as well as to body mass index (BMI). This was done in order to test the hypothesis that cardiovascular complications in diabetics might be mediated by persistent hyperglycaemia.
Materials and Methods
Patients with uncomplicated diabetes mellitus controlled by insulin, metformin or glibenclamide were recruited from the diabetic clinic of the University of Ilorin Teaching hospital, Ilorin. The non-diabetic patients served as controls and were members of staff of the University of Ilorin. All subjects gave informed consent. Subjects who were smokers, with systolic blood pressure 7 . All haemorheological parameters were analyzed within four hours of blood collection. The Hct (%) was analyzed by Hawksley capillary centrifugation at 3000rpm for 10min and RPV was assessed by 14 0 14 capillary viscometry at 37 C . Hct and RPV were measured in duplicate and averaged for each sample. TPP (g/l) was determined by 7, 14 micro-biuret method . Fasting blood glucose concentrations (mmol/l) were determined by coupled enzymatic colourimetric method. Statistical analysis: Data were expressed as means ± SEM (range). Pearson's correlation coefficients were calculated between FBS and Hct, RPV, TPP and BMI in diabetics and non-diabetics. Statistical comparisons among groups were done using the student's t-test. Statistical significance was accepted when p < 0.05. 2 , 4 5 , 6 viscosity and haematocrit . These alterations in haemorheological indices could explain the increase in hyperviscosity state usually associated with increased risk of cardiovascular, cerebrovascular and retinal 3, 7, 8 venous occlusion morbidity more so, that plasma viscosity and haematocrit have been 9 found to be increased in diabetic retinopathy 10 and glaucoma as well as in subjects with 11 blurred vision .
Patients with uncomplicated diabetes mellitus controlled by insulin, metformin or glibenclamide were recruited from the diabetic clinic of the University of Ilorin Teaching hospital, Ilorin. The non-diabetic patients served as controls and were members of staff of the University of Ilorin. All subjects gave informed consent. Subjects who were smokers, with systolic blood pressure 7 . All haemorheological parameters were analyzed within four hours of blood collection. The Hct (%) was analyzed by Hawksley capillary centrifugation at 3000rpm for 10min and RPV was assessed by 14 0 14 capillary viscometry at 37 C . Hct and RPV were measured in duplicate and averaged for each sample. TPP (g/l) was determined by 7, 14 micro-biuret method . Fasting blood glucose concentrations (mmol/l) were determined by coupled enzymatic colourimetric method. Statistical analysis: Data were expressed as means ± SEM (range). Pearson's correlation coefficients were calculated between FBS and Hct, RPV, TPP and BMI in diabetics and non-diabetics. Statistical comparisons among groups were done using the student's t-test. Statistical significance was accepted when p < 0.05.
Results
Ta b l e 1 s h o w s a s u m m a r y o f t h e characteristics of male and female nondiabetics and male and female diabetics. Results show that male non-diabetics and diabetics had significantly higher (p < 0.01) mean values of Hct than women, while there were no significant sex difference in all other parameters. Non-diabetic subjects were not on any hypoglycaemic drugs. Both male and female diabetics had significantly higher values of FBS, RPV and TPP compared to their non-diabetic counterparts (Table 1) . Data are given as : means ± SEM (range); n sample size; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; Hct Haematorit; TPP total plasma protein; RPV relative plasma viscosity; FBS fasting blood sugar; * -p < 0.05 ; ** p < 0.01 ; *** p < 0.001 versus non-diabetics ++ p <0.01 ; +++ p < 0.001 versus male non-diabetics. Data given as means ±; n, sample size; FBS fasting blood sugar; RPV relative plasma protein; TPP total plasma protein; Hct Haematocrit; * p < 0.05; ** p < 0.01; *** p < 0.001 versus nondiabetics. 
DISCUSSION
The results of the present study demonstrate significant increases in relative plasma viscosity (RPV) and total plasma protein (TPP) levels in both male and female normotensive diabetic Nigerians, despite glycaemic control threshold achieved by insulin, metformin or glibenclamide ( Table  1) . The values for fasting blood glucose was similar among the diabetic patients but were significantly higher than the value in nondiabetic subjects. This is in consonance with 2, 4, 15, 16 the findings of previous studies . There were no significant differences in haemorheological markers among the three diabetic groups. The present study extends the findings of previous studies in nondiabetic and diabetic patients with a wider age range (25 76 years), matched for age, sex, body mass index and blood pressure were studied. We also examined the associations between haemorheological markers, body mass index and fasting blood glucose levels and the extent to which hyperglycaemia might contribute to the relationships in either sex.
The contribution of blood glucose to plasma viscosity has been uncertain, as earlier studies did not determine other main markers of plasma viscosity such as plasma protein levels. This study shows that hyperglycaemia contribute strongly, possibly, independently of other factors, to plasma hyperviscosity in diabetic patients. There was weak correlation between blood glucose and plasma viscosity in non-diabetic patients while the association between plasma viscosity and glucose levels was strongly positive in either sex. However, there was a weak positive correlation between relative plasma viscosity and total plasma protein levels which does not reach statistical significant level (r = 0.45, p > 0.05) in both sexes. The weak relationship between relative plasma viscosity and total plasma protein levels also supports the contention that persistent hyperglycaemia significantly accounts for elevated plasma viscosity in these patients. This finding is in the same line of thought with a previous study in diabetic animals in which there was a significant univariate inverse correlations between cerebral blood flow and hyperglycaemia 17 induced by intraperitonial glucose injection and in community-based studies which f o u n d t h a t d i a b e t i c m e l l i t u s w a s independently associated with plasma viscosity, though blood glucose levels were 5, 18 not quantified .This study confirms earlier observations that haematocrit is significantly 7 higher in men compared to women and this may explain the higher risk of cardiovascular disease in men because it has been shown that haematocrit is positively related to 7, 8 incident cardiovascular disease . The higher haematocrit values in men with or without diabetes mellitus than in their women counterpart could indicate higher whole blood viscosity because whole blood viscosity is mainly determined by the 8 haematocrit . As a result of this, sex difference in haematocrit appears to be secondary to increase in plasma volume due 7 to hormonal fluid retention in women . This study shows an insignificant decrease in haematocrit in patients with diabetics. Several independent studies have reported variable changes in the haematocrit values of [2] [3] [4] [5] [6] 16, 17 diabetic population .A weak negative correlation was found between blood glucose levels and haematocrit in either sex in the present study ( Table 3 ), suggesting that persistent hyperglycaemia is likely to cause an adaptive response in order to minimize the impact of elevated plasma viscosity and total plasma protein in circulation.
The associations of plasma viscosity and blood glucose with body mass index in the present study were comparable to previous relationship between plasma viscosity or fasting blood glucose with body mass index. This finding suggests that the increases in plasma viscosity and total protein associated with hyperglycaemia in diabetic Nigerians is not obesity-induced. Failure of insulin, metformin or glibenclamide treatment to normalize plasma viscosity is consistent with 19, 20 previous studies in caucasians . These workers reported that high insulin levels were responsible for hyperviscous plasma in the diabetics, possibly due to its anabolic effect. Taken together, the results of this study have demonstrated that hyperglycaemia strongly contribute to elevated plasma viscosity. The hyperviscosity induced by hyperglycaemia might promote diabetic musculo-skeletal pains . We therefore suggest monitoring plasma viscosity in d i a b e t i c p a t i e n t s w i t h p e r s i s t e n t hyperglycaemia who has any of these symptoms.
In conclusion, this study has shown that plasma viscosity and plasma protein levels were higher in diabetic patients on insulin, metformin, or glibenclamide treatment. In addition, elevated plasma viscosity strongly correlated positively with hyperglycaemia. The results suggest that hyperviscous plasma might reduce perfusion in diabetic microangiopathy and / or retinopathy. Hence, indicating the necessity of very early usage of rheomodulators in diabetic patients.
